![Scott Wasserman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott Wasserman currently works at Kyttaro Ltd., as Director from 2022.
| Companies | Position | Start |
|---|---|---|
KYTTARO Ltd.
 KYTTARO Ltd. BiotechnologyHealth Technology Develops monoclonal antibodies for potential treatment of atherosclerotic cardiovascular diseases | Director/Board Member | 07/11/2022 |
Active
Inactive
Listed companies
Private companies
| Private companies | 1 |
|---|---|
KYTTARO Ltd.
KYTTARO Ltd. BiotechnologyHealth Technology Develops monoclonal antibodies for potential treatment of atherosclerotic cardiovascular diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
